NCT03774290View on ClinicalTrials.gov

Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

February 5, 2020

Study Completion Date

March 16, 2020

Conditions

Asthma

Interventions

DRUG

PBF-680

PBF-680 is an adenosine A1 receptor antagonist

DRUG

Placebo oral capsule

Oral gelatine capsule

Trial Locations (1)

08025

Unitat de Pneumologia Experimental, Barcelona

All Listed Sponsors

collaborator

Pivotal S.L.

INDUSTRY

lead

Palobiofarma SL

INDUSTRY

NCT03774290 - Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients | Biotech Hunter | Biotech Hunter